The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.
 
Jacob Kaufman
Consulting or Advisory Role - AstraZeneca
 
Dwight Hall Owen
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Onc.AI (Inst); Palobiofarma (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Genentech
 
Regan Michelle Memmott
Consulting or Advisory Role - Takeda
 
Gregory Alan Otterson
Consulting or Advisory Role - Novocure; OncLive/MJH Life Sciences
Research Funding - Apollomics (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Revolution Medicines (Inst)
 
Kai He
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Geneplus; Iovance Biotherapeutics; Lyell Immunopharma; Mirati Therapeutics; Perthera
Research Funding - Abbvie (Inst); Adaptimmune (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Iovance Biotherapeutics (Inst); Mirati Therapeutics (Inst); Oncoc4 (Inst)
 
Carolyn J Presley
Consulting or Advisory Role - Jazz Pharmaceuticals; Jazz Pharmaceuticals; Onc Live; Regeneron
 
Daniel Spakowicz
No Relationships to Disclose
 
Peter G. Shields
No Relationships to Disclose
 
Xiaoli Zhang
No Relationships to Disclose
 
Theresa A. Boyle
Stock and Other Ownership Interests - Ionis Pharmaceuticals
Research Funding - Bristol Meyers Squibbs
 
W. Douglas Cress
Patents, Royalties, Other Intellectual Property - Treatment of STK11 loss cancer Inventors: Douglas Cress, Nicholas Gimbrone, John Cleveland Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc. Filing Date: May 28, 2021 Assigned U.S (United States). Patent Application No. 17/298,251
 
Kris Wood
Leadership - Celldom; Tavros Therapeutics
Stock and Other Ownership Interests - Celldom; Tavros Therapeutics
Consulting or Advisory Role - Apple Tree Partners; Tavros Therapeutics
Patents, Royalties, Other Intellectual Property - I am named on patents owned by Celldom Inc
 
Neal E. Ready
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Celgene; G1 Therapeutics; Jazz Pharmaceuticals; Merck; Merck Serono; Novartis; Pfizer; Regeneron; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Bristol-Myers Squibb; Memgen (Inst); Merck
 
Lang Li
No Relationships to Disclose
 
Zihai Li
Stock and Other Ownership Interests - Agenus (I); yuMed
Honoraria - Alphamab; Heat Biologics; Henlius
Consulting or Advisory Role - Abbvie; Alphamab; HANCHORBIO; Heat Biologics; Henlius; Ikonisys
Research Funding - Bristol-Myers Squibb; Heat Biologics
Patents, Royalties, Other Intellectual Property - Have a patent on HSP vaccine technology that was license to Agenus
 
David Paul Carbone
Employment - James Cancer Center
Honoraria - AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical
Consulting or Advisory Role - Abbvie; Arcus Biosciences; AstraZeneca; Bristol-Myers Squibb; Curio Science; EMD Serono; Genentech/Roche; GlaxoSmithKline; Intellisphere; InThought; Iovance Biotherapeutics; Janssen; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Lilly; Merck; Merck KGaA; Mirati Therapeutics; MSD Oncology; NCCN/AstraZeneca; Novartis; OncLive/MJH Life Sciences; Pfizer; PPD; Regeneron; Roche; Sanofi